A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Hypertrophy is an increase in cell size through increased protein synthesis and organelles, occurring in response to increased functional demand (e.g., muscle hypertrophy with exercise). Hyperplasia is an increase in cell number through proliferation, common in hormone-responsive tissues and regenerating tissues. Both represent adaptive responses that enhance organ function, but can become pathologic if excessive.
Study examples in different tissues: smooth muscle hypertrophy in hypertension, cardiac hypertrophy with aortic stenosis, pancreatic β-cell hyperplasia with insulin resistance. Compare with maladaptive responses.
Hypertrophy and hyperplasia are not the same process. Hypertrophy does not involve cell division, while hyperplasia requires it. Some organs show both simultaneously.
From your study of cell biology, you know that cells are not static — they continuously monitor signals from their environment and adjust their behavior accordingly. Cellular adaptation is the organized, controlled response to sustained changes in demand or stress. The two primary adaptive strategies differ in one fundamental respect: does the cell grow larger, or does the tissue produce more cells? That distinction — hypertrophy versus hyperplasia — depends on whether the cell type can still divide.
Hypertrophy occurs when non-dividing or slowly-dividing cells must do more work. A classic example is skeletal muscle: when you repeatedly stress a muscle against resistance, individual muscle fibers respond by synthesizing more contractile proteins (actin and myosin), expanding their mitochondrial content, and enlarging the sarcoplasmic reticulum. The cell doesn't split — it becomes bigger and more capable. The same logic applies to the heart muscle: when the left ventricle must pump against chronically elevated resistance (as in hypertension or aortic stenosis), cardiomyocytes hypertrophy because mature cardiac muscle cannot divide. The wall thickens, initially compensating well, but over years the enlarged heart becomes stiffer and more prone to arrhythmia. The adaptation that initially saved function eventually threatens it.
Hyperplasia occurs in tissues whose cells retain proliferative capacity. The uterine endometrium proliferates in response to estrogen each month; the liver can regenerate from 30% of its mass through hepatocyte division; bone marrow continuously produces new blood cells in response to erythropoietin. Hormone-driven hyperplasia is physiologic (breast tissue during puberty and pregnancy), but the same growth signals can become pathologic when unregulated — benign prostatic hyperplasia causes urinary obstruction, and endometrial hyperplasia driven by unopposed estrogen can progress to malignancy. Some tissues respond with both strategies simultaneously: the pregnant uterus hypertrophies (each smooth muscle cell enlarges) and undergoes hyperplasia (new smooth muscle cells form), enabling the massive increase in uterine mass needed to house a term fetus.
The adaptive response is fundamentally reversible if the driving stimulus is removed — a key distinction from neoplasia, which is irreversible and no longer responds to normal growth controls. Trained muscle shrinks with detraining; the hypertensive heart can regress with blood pressure control. Understanding this reversibility matters clinically: it explains why treating the underlying cause (controlling blood pressure, relieving the outflow obstruction) is the appropriate intervention, not simply managing symptoms. Pathologic hypertrophy or hyperplasia warns that the normal regulatory machinery is under sustained stress — it is both a clue and a window before irreversible damage occurs.